Fennec Pharmaceuticals (FENC) Receivables (2022 - 2025)
Fennec Pharmaceuticals (FENC) posted Receivables of $23.2 million for Q4 2025, up 20.05% on a QoQ basis from $19.3 million in Q3 2025, and up 80.23% year-over-year from $12.9 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Receivables (2022 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Receivables history runs 4 years deep, the most recent figure standing at $23.2 million for Q4 2025.
- Quarterly Receivables rose 80.23% year-over-year to $23.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.2 million (up 80.23% YoY) and the FY2025 annual result came in at $23.2 million, up 80.23% from the prior year.
- Receivables was $23.2 million for Q4 2025 at Fennec Pharmaceuticals, up from $19.3 million in the prior quarter.
- Across five years, Receivables topped out at $23.2 million in Q4 2025 and bottomed at $1.5 million in Q4 2022.
- A 4-year average of $11.0 million and a median of $12.3 million in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2024 — Receivables soared 510.46% — and 2025, when it surged 42.15%.
- Fennec Pharmaceuticals' Receivables stood at $1.5 million in 2022, then jumped by 470.49% to $8.8 million in 2023, then soared by 46.18% to $12.9 million in 2024, then jumped by 80.23% to $23.2 million in 2025.
- Business Quant data shows FENC's Receivables at $23.2 million in Q4 2025, $19.3 million in Q3 2025, and $17.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 23.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.22 Mn |
| Sep 30, 2025 | 19.34 Mn |
| Jun 30, 2025 | 17.50 Mn |
| Mar 31, 2025 | 15.45 Mn |
| Dec 31, 2024 | 12.88 Mn |
| Sep 30, 2024 | 12.91 Mn |
| Jun 30, 2024 | 12.31 Mn |
| Mar 31, 2024 | 10.27 Mn |
| Dec 31, 2023 | 8.81 Mn |
| Sep 30, 2023 | 4.53 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.55 Mn |